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Effects of ultrapure and non-sterile dialysate on the inflammatory
response during in vitro hemodialysis. Several studies support the hypoth-
esis that bacterial contamination of the dialysate stimulates the inflamma-
tory response to hemodialysis (HD) and increases the long-term morbidity
of HD patients; this phenomenon could also be modulated by the nature
of the HD membrane. Therefore, this study was designed to compare the
effects of non-sterile (NSBD, mean endotoxin content SEM 97 22
EU/ml) and ultrapure bicarbonate dialysate (UPBD, sterile and pyrogen-
free, obtained by ultrafiltration through polyamide) on several aspects of
the inflammatory reaction during in Vitro HD. The HD sessions (7 in each
experimental group) were performed using miniaturized new cuprophane(CU) and polyacrylonitrile (PAN) hollow fiber dialyzers, and closed
dialysate and blood circuits (the latter filled with heparinized blood from
healthy donors). Plasma C3aDesarg levels were significantly increased
after 15 minutes (ti) and increased further after three hours (t2) of CU
HD, while during PAN dialysis they decreased from tO to ti and t2;
however, no difference appeared between experiments with NSBD and
UPBD. Granulocyte (PMN) and monocyte (MNC) expression of LFA-i,
Mac-i, and CD45 at the start (tO), ti and t2 was quantitated by flow
cytometry analysis, after staining of the cells with specific fluorescinated
monoclonal antibodies. In contrast with published data of in vivo HD,
LFA-i was overexpressed at ti and peaked at t2, which suggests that the
leukocytes expressing more LFA-1 leave the systemic circulation during in
vivo HD. During CU HD, Mac-I and CD45 on PMN and MNC were
significantly increased at tI, and still more at t2. During PAN HD, Mac-i
and CD45 remained unchanged at ti, but increased significantly at t2 on
PMN as on MNC. Again, no significant difference was found between
NSBD and UPBD in LFA-I, Mac-i and CD45 expression on PMN and
MNC, during both CU and PAN HD. After three hours of dialysis, plasma
levels of TNF-a, but not of IL-6, were significantly increased with CU and
PAN. Again, no difference appeared when NSBD and UPBD were
compared. Moreover, the lack of influence of bacterial contamination of
the dialysate on TNF-a production was confirmed when MNC were
cultured up to 24 hours after the end of the HD session. We conclude that
complement activation products, either in plasma (CU) or those adsorbed
on the HD membrane (CU and PAN) play the major role in the
overexpression of 132-integrins and CD45 by PMN and MNC during HD.
Also, bacterial products (at the levels that can be found in clinical
conditions) do not influence either /32-integrin overexpression or TNF-a
production induced by the dialysis membrane.
The concept that bacterial products in the dialysate could
contribute to the inflammatory reaction that is associated with
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hemodialysis (HD) is born with the so-called "interleukin hypoth-
esis" [11. This concept has now found some support in several
experimental and clinical data. So, during acute in vitro experi-
ments, HD with non-sterile dialysate has been shown to be
associated with a greater interleukin-1 (IL-I) production than
with sterile dialysate [2—5]. Moreover, in a group of HD patients
shifted for one month from non-sterile (NSBD) to ultrapure
bicarbonate dialysate (UPBD), plasma levels of IL-i and tumor
necrosis factor (TNF) were found to decrease significantly [6].
Also, some data suggest that both serum levels of /32 microglobu-
lin [7] and the incidence of the carpal tunnel syndrome [8] are
lower in patients dialyzed with ultrapure dialysate. Consequently,
the use of sterile, endotoxin-free dialysate has been advocated by
some to minimize the inflammatory response to HD [5, 6], and
several manufacturers have already integrated ultrafilters in their
dialysate generators to provide UPBD. The present study was
performed to further analyze the influence of bacterial contami-
nation of the dialysate (and also a possible modulation according
to the nature of the HD membrane) on several components of the
inflammatory response. The effects of UPBD and NSBD were
thus compared during in vitro cuprophane (CU) and polyacrylo-
nitrile (PAN) HD on complement activation, monokines secre-
tion, and on the expression by granulocytes (PMN) and mono-
cytes (MNC) of several surface molecules involved in cell
adhesion and activation.
Methods
In vitro hemodialysis
We performed in vitro HD sessions of three hours using closed
loop blood and dialysate circuits. The dialyzers consisted in
miniaturized new ethylene oxide-sterilized CU or PAN hollow
fiber dialyzers, provided by Hospal (Meyzieu, France). The blood
circuit was filled with heparinized blood from healthy donors (2
females, 1 male; ages 30 to 42 years). The dialysate consisted
either in non-sterile bicarbonate dialysate (NSBD) or ultrapure
bicarbonate dialysate (UPBD). Blood and dialysate were main-
tained at 37°C and recirculated with peristaltic pumps at 10
ml/min in a countercurrent manner, with no net ultrafiltration
(volumetric control by means of reservoirs fluid level). The HD
circuits were assembled using a careful aseptic technique. The
apyrogenicity of the blood and of the dialysate circuits (in the
experiments with UPBD) was confirmed at the start and by the
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Table 1. Cytokines inducing capacity of non-sterile (NSBD) and
ultrapure bicarbonate dialysate (UPBD) as compared to RPMI 1640
NSBD UPBD RPMI
No. 5% 10% 5% 10% 5% 10%
TNF-a pg/mI 1 3974 9124  15 15  15 15
2 577 1614 15  15 15 15
Mean SEM 3822 1905  15  15
IL-6pg/ml 1
2
2084 14863
6972 12220
30 81
34 86
30 60
 30 30
Mean SEM 9034 2838 58 15 39 7
NSBD, UPBD, and a cell culture medium serving as control (RPMI
1640) were mixed with whole blood of 2 healthy donors to final concen-
trations of 5 volume % (5%) and 10 volume % (10%). After 5 hours of
incubation at 37°C, soluble TNF-cs and IL-6 concentrations were mea-
sured in plasma. No. is identification number of the healthy blood donors.
end of each HD session by the absence of detectable endotoxin
levels.
Preparation and characteristics of UPBD and NSBD
Both NSBD and UPBD were prepared from the standard
bicarbonate dialysate (SBD) in use in our in-hospital HD facility.
The NSBD consisted in the SBD that had been left overnight at
room temperature to allow further bacterial proliferation. The
most prevalent bacteria isolated from dialysate were Pseudomonas
strains (paucimobilis, cepacia, putida) and Xanthomonas malto-
philia. Chemical composition of NSBD was found unchanged
after this delay (per liter: Na 145, K 3, Cl 111, acetate 3,
bicarbonate 32, Mg 1, and Ca 3 mEq; dextrose 1.5 g). The final
endotoxin levels of this NSBD were: (a) CU and PAN experi-
ments together, mean SEM 97 22 EU/mI, range 1.5 to 225,
geometric mean 43; (b) CU experiments, 104 33, 1.5 to 225, and
40, respectively; (c) PAN experiments, 88 32, 6 to 225, and 48,
respectively. The UPBD consisted in the SBD that had been
previously ultrafiltered through a polyamide membrane (Ultrafil-
ter U2000, Gambro, Sweden), a procedure known to retain
endotoxin [9, 10], which was repeatedly confirmed by our own
studies (data not shown). In other preliminary studies, we had also
assessed the cytokines inducing capacity of UPBD and NSBD as
compared to a cell culture medium serving as a negative control
(RPMI 1640, Gibco, Life Technologies, Paisley, UK; no detect-
able endotoxin, that is, <0.015 EU/ml). This was done as follows:
a sample of NSBD (endotoxin concentration of 161 EU/ml),
UPBD, and RPMI was diluted to final concentrations of both 5
and 10 volume% with whole blood of two different healthy
donors. After five hours of incubation at 37°C, these samples were
centrifuged and the concentrations of IL-6 and TNF-a were
determined in the supernatants, using the assays described below.
Results are presented in Table 1. By contrast with NSBD, UPBD
compared with RPMI by having no residual monokines inducing
capacity, confirming previous observations of Dinarello and col-
leagues [10].
Comparison of UPBD and NSBD
Both with CU and PAN, we compared the effects of UPBD and
NSBD (7 experiments in each situation) on the expression of
Mac-i, LFA-1, and CD45 at the surface of PMN and MNC. The
expression of these molecules was evaluated at the start (to), after
15 minutes (ti), and after 180 minutes (t2) of in vitro HD. We also
compared the effect of UPBD and NSBD on complement activa-
tion, by measuring plasma C3aDesarg concentrations on several
occasions at tO, ti, and t2. All the samples were obtained from the
afferent blood line.
Also, the plasma levels of TNF-a and IL-6 were measured at tO
and t2 during CU and PAN dialysis, comparing the respective
influence of UPBD and NSBD (7 experiments in each condition).
Moreover, as MNC could be only primed during HD but produce
monokines only several hours after the end of the session, we also
studied the production of TNF-cs by MNC maintained in culture
up to 24 hours after the HD procedure.
Measurement of endotoxin levels
Endotoxin levels were measured using a chromogenic endo-
toxin specific assay (Seikagaku Corporation, Tokyo, Japan). This
assay was chosen to get rid of the false positive results frequently
observed with other assays while measuring endotoxin concentra-
tions in the blood circuits of cuprophane hollow-fiber dialyzers,
and which are due to non-pyrogenic cellulose-derived reactive
material [11]. Results are expressed as EU/mI. The sensitivity of
the assay is 0.15 and 0.015 EU/ml in blood and dialysate,
respectively.
Measurement of plasma C3aDesarg concentrations
To avoid any further complement activation after sampling,
blood was collected to tubes with EDTA, kept on ice and
centrifuged immediately. Plasma was removed and frozen at
—80°C. The concentrations of C3aDesarg were measured subse-
quently with a commercial radioimmunoassay (Amersham, Buck-
inghamshire, UK).
Measurement of plasma TNF-cs and IL-6 concentrations
Plasma TNF-a and IL-6 levels were measured using commer-
cial immuno-enzymetric assays (TNF-a-EASIA and IL-6-EASIA,
respectively, Medgenix, Brussels, Belgium).
Delayed monokines production after in vitro HD
To study whether HD—in particular using NSBD—could prime
MNC to produce monokines after the end of the procedure, the
"delayed" TNF-a production was studied as follows. Blood was
harvested after three hours of in vitro HD and the peripheral
mononucleated cells (PBMC) were separated by density gradient
centrifugation (Lymphoprep®, Nycomed, Oslo, Norway). The
proportion of MNC among the PBMC was counted manually on
100 cells after staining with the May-Grunwald-Giemsa stain. The
PBMC were then resuspended (2 x 106 cells/mI) in non-adherent
polypropylene Falcon tubes (Becton Dickinson, Plymouth, UK)
with RPMI 1640 containing fetal calf serum (5 vol%), 2 m
L-glutamine, 1 m sodium pyruvate, 1% MEM (non essential
amino acids), 100 IU/ml penicillin, 100 mg/ml streptomycin, and 5
X 10 M mercapto-ethanol (all from Gibco, Paisley, UK); the
cells were cultured at 37°C in a humidified atmosphere with 5%
C02, either for 3 (t2÷3 hr) or for 24 hours (t224 hr). Controls
consisted in PBMC obtained at the start of the HD sessions (to),
handled and cultured in the same manner, respectively, for 3 (t0±3
hr) and 24 hours (t0±24 hr) The TNF-a levels were measured both
in the MNC ("intra-cellular TNF-a") and in the culture superna-
tants with the assay used for plasma TNF-a determinations. By
the end of the culture periods, the samples were centrifuged and
the culture supernatants and the PBMC pellets were separated;
the latter were resuspended in 1 ml RPMI for the determinations
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Table 2. Plasma C3aDesarg levels (nglml) during in vitro hemodialysis (HD)
Conditions N tO ti P° t2 p' pc
(A) CU/NSBD 7 331 68 2390 450 0.003 14170 3430 0.007 0.011
(B) CU/UPBD 7 389 1 3554 1334 0.043 7563 2819 0.042 NS
AVS.Bd NS NS NS
(C) PAN/NSBD 3 220 75 117 45 NP 69 7 NP NP
(D) PAN/UPBD 4 264 100 101 34 NP 88 13 NP NP
PAN (C + D)° 7 245 61 108 25 0.018 80 8
—
0.022 NS
Abbreviations are: CU, cuprophane; PAN, polyacrylonitrile; NSBD, non-sterile bicarbonate dialysis; UPBD, ultrapure bicarbonate dialysate; N,
number of experimental HD sessions; tO, start of HD; ti and t2, after 15 and 180 minutes of HD, respectively; NS, not significant; NP, analysis not
performed due to too small size of data sets.
a vs. t2, h t2 vs. to, and t2 vs. ti respectively, by Student's t-test for paired data
d A vs. B by Student's t-tcst for unpaired data
All data with PAN were pooled (NSBD and UPBD) to describe evolution of C3aDesarg levels during HD
of the intracellular TNF-a content of the MNC. Therefore, the
PBMC were lysed by three successive freeze-thaw cycles at —80°C
as previously described by N. Haeffner-Cavaillon et a! [121. The
MNC lysates were then centrifuged at 2000 g for 10 minutes at 4°C
and the TNF-cs levels were measured in the supernatants ("intra-
cellular TNF-a levels"). Both intracellular TNF-cx levels and
TNF-a concentrations in the culture supernatants were expressed
as pg/per 2 X i0 MNC. Three experimental HD sessions were
performed using PAN and NSBD; as no TNF-a production was
observed no additional experiments were made with PAN and
UPBD. On the contrary, because CU dialysis was associated with
a significant TNF-a production, three experiments were per-
formed with NSBD and three with UPBD to compare the effects
of both dialysates. In all the studies on delayed TNF-cs production,
the endotoxin content of the NSBD was adjusted to 125 EU/mI.
Measurement of Mac-I, LFA-1, and CD45 expression by PMN
and MNC
Mac-i, LFA-i, and CD45 expression was assessed using two-
color direct immunofluorescence staining of PMN and MNC, as
previously detailed [13]. Briefly, 100 tl of blood is incubated for
30 minutes at 4°C with selected monoclonal IgG fluorescinated
antibodies at saturating concentrations, in a double labeling
procedure. These antibodies were anti-CD45 fluorescein isothio-
cyanate (FITC) - anti-CD14 phycoerythrin (PE) (Becton Dickin-
son, Mountain View, CA, USA), anti-CD11a FITC (Immunotech,
Marseille, France) - anti-CD14 PE (Becton Dickinson), and
anti-CD14 FITC (Becton Dickinson) - anti-CDI1b PE (Becton
Dickinson). As negative controls we used monoclonal isotopic
IgG purchased from DAKO (Glostrup, Denmark). Red blood
cells were lysed after staining, using a commercial solution (FACS
lysing solution, Becton Dickinson). The samples were centrifuged,
washed in phosphate-buffered saline (PBS) and resuspended in
PBS for flow cytometric analysis on a FACstar Plus analyzer
(Becton Dickinson). PMN and MNC were identified using their
morphological characteristics (forward vs. side scatter resolution);
discrimination between both cell types was further confirmed by
the intensity of their CD14 expression. Acquisition was made on
10,000 cells. The green and red fluorescence was quantitated using
dual-laser excitation of FITC and PE with logarithmic amplifica-
tion (band pass filter 530-30 nm for FITC and 575-26 nm for PE
separation). Results were expressed as mean fluorescence inten-
sity channel (MFC).
Table 3. Plasma TNF-o and IL-6 levels (pglml) at the start (to) and
after 3 hours (t2) on in vitro hemodialysis
TNF-a
at tO
TNF-a
at t2
t2 vs.
toa
IL-6
at tO
IL-6
at t2
t2 vs.
tO°
CU
(a) NSBD
(b) UPBD
avs. b5
< 15
< 15
127 38
134 44
NS
0.033
0.042
< 20
<20
40 16
34 12
NS
NS
NS
PAN
(a) NSBD
(b) UPBD
avs. h"
< 15
< 15
42 10
49 13
NS
0.041
0.044
<20
<20
20 13
25 5
NS
NS
NS
Abbreviations are: CU, cuprophane; PAN, polyacrylonitrile; NSBD and
UPBD, non-sterile and ultrapure bicarbonate dialysate respectively; NS,
not significant. TNF-a and IL-6 were always undetectable at tO.
Data are mean values SEM.
Student's t-test for paired (°) and unpaired (") data, respectively
Data presentation and statistical analysis
All data are expressed as mean values SEM. The evolution of
Mac-i, LFA-1, and CD45 expression on leukocytes during the HD
sessions were analyzed using the Wilcoxon's test for coupled
differences (intra-experiments analysis). However, as baseline
expression of Mac-i, LFA-1, and CD45 may vary rather widely
according to the donor and from day to day, comparison between
experiments with UPBD and NSBD was performed as follows.
The differences in MFC values (MFC) between tO, ti and t2
were calculated as i = ti — tO and 2 = t2 — tO. Statistical
analysis between experiments with UPBD and NSBD was made
by comparing the values of the 1 and z2 by the Wilcoxon's test
(inter-experiment analysis). For statistical analysis, plasma con-
centrations of TNF-a and IL-6 below the detection limit were
assumed to be equal to the detection limit. Comparison of
C3aDesarg, TNF-a, and IL-6 levels was performed by the Stu-
dent's f-test for unpaired or paired data, as required. The tests
were considered significant when cs or P  0.05.
Results
Endotoxin was never detectable in the blood circuits, even by the
end of the HD sessions with NSBD
Complement activation. During CU HD, plasma C3aDesarg
levels were elevated at ti, and were further increased at t2 (Table
2). On the contrary, during PAN dialysis, plasma C3aDesarg
concentrations were lower at ti and t2 than at the start of HD.
The level of complement activation was never different with
NSBD as compared to UPBD (Table 2).
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Table 4. Delayed production of TNF-a by MNC obtained before (tO) and after 3 hours (t2) of in vitro hcmodialysis and maintained in culture for
3 (t,,*,, and t2+ih) and 24 hours (to+24h and t2+24h), respectively
Membrane Dialysate Experiment
Intracellular TNF-a pg/per 2 x 1O MNC TNF-a in culture supernatants pg/per 2 >< 1U5 MNC
tO±3h t2+ih tO+24h t2+24h tO+3h t23h tO+24h tZ+24h
PAN NSBD 1
2
3
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
CU NSBD 1
2
3
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
40
<20
38
<20
<20
<20
854
142
64
CU UPBD 1
2
3
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
<20
23
92
<20
<20
<20
328
1066
70
Abbreviations are: CU, cuprophane; PAN, polyacrylonitrile; NSBD and UPBD, non-sterile (125 EU/mI) and ultrapure bicarbonate dialysate,
respectively; MNC, monocytes.
See Methods section for detailed protocol.
Table 5. Expression of Mac-i, LFA-1, and CD45 at the surface of
PMN during in vitro HD
Glycoprotein Time CU/UPBD CU/NSBD PAN/UPBD PAN/NSBD
Mac-i tO
ti
t2
324 92
625±132'
982 157°
139 33
400±134°
961 166C
176 52
161±29NS
467 79C
285 107
284±59NS
718 133°
LFA-1 tO
ti
t2
45 5
50 3°
50 4°
41 3
45 3"
47 3"
42 4
44 9
49 4"
47 5
49 6NS
52 6"
CD45 to
ti
t2
58 14
92 16"
138 15'
43 5
74 15'
116 12"
48 10
44 5 NS
78 8C
57 9
59 9 NS
102 160
Abbreviations are: CU, cuprophane; PAN, polyacrylonitrile; UPBD,
ultrapure bicarbonate dialysate; NSBD, non-sterile bicarbonate dialysate;
to, start of hemodialysis session; ti and t2, after 15 and 180 minutes of
dialysis, respectively.
Statistical significance is given as compared to: a a <0.05, h a < 0.025,
a < 0.01 (Wilcoxon test for coupled differences)
HD-associated production of monokines
TNF-a and IL-6 were never detectable in plasma at the start of
the experimental HD sessions (Table 3). Both with CU and with
PAN, the plasma levels of TNF-a had significantly increased after
three hours of HD compared to tO (Table 3). However, no
difference appeared with the use of UPBD compared to NSBD,
whatever the membrane (Table 3). In addition, the levels of
TNF-a by the end of dialysis were higher with CU than with PAN
(experiments with UPBD and NSBD together: CU versus PAN,
131 28 versus 45 26, P < 0.001. The IL-6 plasma levels were
slightly increased at the end of dialysis as compared to tO, as well
with CU as with PAN; this increase, however, did not reach the
level of significance. Again, when experiments with NSBD and
UPBD were compared, there was no significant difference in the
plasma concentrations of IL-6 at t2, no matter which membrane
was used.
Production of TNF-a by MNC harvested at the start and by the
end of HD and cultured for 3 or 24 hours can be found in Table
4. With PAN, despite the use of NSBD, no TNF-a was found
either within MNC nor in culture supernatants. With CU dialysis,
no intracellular TNF-a was detected. However, low levels of
TNF-a were found in the supernatants of MNC cultured for three
hours (Table 4, 23 hr vs. t03 i,-) and, most especially, significant
levels of TNF-cs were found in the culture supernatants after 24
Table 6. Expression of Mac-i, LFA-1, and CD45 at the surface of
MNC during in vitro HD
Glycoprotein Time CU/UPBD CU/NSBD PAN/UPBD PAN/NSBD
Mac-i tO
ti
t2
251 74
518±121°
789 154°
175 52
341±92c
727 1360
221 71
233±51NS
541 92°
394 134
411±120N5
754 146°
LFA-1 tO
tI
t2
164 76
184 73"
224 70°
80 8
102 12°
139 12°
79 12
90 14°
198 18°
102 15
122 19
168 26b
CD45 tO
ti
t2
174 72
223 75°
287 67°
93 9
133 20°
198 18°
95 12
108 8 NS
163 16"
129 18
144 20 NS
223 32°
Abbreviations are: CU, cuprophane; PAN, polyacrylonitrile; UPBD,
ultrapure bicarbonate dialysate; NSBD, non-sterile bicarbonate dialysate;
to, start of hemodialysis session; ti and t2, after 15 and 180 minutes of
dialysis, respectively.
Statistical significance is given as compared to: a a < 0.05, ' a <0.025,
a < 0.01 (Wilcoxon test for coupled differences).
hours (Table 4, 224 hr vs. t024 hr). However, this CU-induced
delayed production of TNF-cs was obviously not different with
NSBD compared to UPBD.
Expression of Mac-i, LFA-i, and CD45 by PMN and MNC
The evolution during CU and PAN dialysis of Mac-i, LFA-i,
and CD45 at the surface of PMN and MNC are detailed in Tables
5 and 6, respectively. The behavior of Mac-i and of CD45 were
strictly identical. During CU dialysis, there was an up-regulation
of Mac-i and CD45 on both PMN and MNC, that was already
present at ti, and still increased at t2, whatever the dialysate.
During PAN dialysis, with both UPBD and NSBD, Mac-i and
CD45 remain unchanged at ti but increased significantly by t2, as
well on PMN as on MNC. The expression of LFA-1 also increased
at ti and peaked at t2, whatever the cell type, the HD membrane,
or type of dialysate (Table 6). However, the increase of LFA-1
expression on PMN at ti during PAN dialysis with NSBD failed to
reach significance.
Comparison between UPBD and NSBD for the 1 and z2 of
Mac-i, LFA-i, and CD45 did not show any significant difference,
neither for PMN nor for MNC, whether or not the HD was run on
CU or PAN (data not shown).
Discussion
Bacterial products such as endotoxins and muramyl peptides
are potent stimuli of inflammatory reaction, namely resulting in
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Table 7. Experimental conditions of the studies that have assessed the role of bacterial contamination of the dialysate on monokines production
during in vitro hemodialysis
Ref. BC DC EXT source ETX concentration pg/ml Monokines studies
[2] B PBS Purified ETX 1 IL-i activity in the supernatants of MNC cultures
[4] MEM/S MEM E. coli 0.5 IL-i inducing activity of "blood" samples on MNC
5%sAlb/S Microfiltrate
iO%FHP/S
[5] S S
5/Bic
Purified ETX 0.8—i.i MNC-associated IL-i activity
[18] S S Purified ETX 10.8 IL-1/TNF-n in plasma/cell culture supernatants
S/sAlb
Abbreviations are: BC and DC, fluid used in the blood and dialysate circuits respectively; ETX, endotoxin; B, blood; MEM, minimal essential
medium; S, saline; sAIb, seralbumin; FHP, fresh human pl4sma; PBS, phosphate buffered saline, Bic, sodium bicarbonate, IL-i, interleukin-i, TNFa,
tumor necrosis factor a, MNC, monocytes.
complement activation [14], increased monokines production
[15], and up-regulation at the surface of leukocytes of molecules
involved in cell adhesion and/or activation, such as Mac-i [16] and
CD45 [17]. Also, it has been suggested that bacterial products in
the dialysate could participate in the inflammatory reaction to
hemodialysis [1—8]. Therefore, we performed this in vitro study to
compare the effects of UPBD and NSBD on several aspects of the
inflammatory response during cuprophane and polyacrylonitrile
hemodialysis.
First, it must be emphasized that the limulus amoebocyte lysate
(LAL) assay never detected endotoxin on the blood side of our
experimental hemodialysis circuits, even after three hours of
cuprophane or polyacrylonitrile hemodialysis with NSBD. This is
consistent with other data in the literature. Even those groups
whose results indirectly suggest that endotoxin can permeate the
hemodialysis membrane, were unable to detect endotoxin on the
blood side with the LAL-assay, despite the use of very high
endotoxin concentrations in the dialysate [4, 5, 18].
During cuprophane hemodialysis, we observed a significant
increase of C3aDesarg levels (Table 2) reflecting the well-known
complement activation occurring with this membrane [19]. How-
ever, there was no difference in the level of complement activation
between cuprophane hemodialysis with NSBD and UPBD.
C3aDesarg levels were somewhat higher after three hours of
hemodialysis with NSBD as compared to UPBD, but the differ-
ence was far from significant (P = 0.16, NS). No complement
activation was observed in the blood phase during polyacryloni-
trile hemodialysis, which is consistent with the classical data in the
literature [19]. On the contrary, plasma C3aDesarg levels even
decreased significantly during our in vitro experiments, which is
presumably due to C3aDesarg adsorption onto the polyacryloni-
trile membrane [19]. Again, C3aDesarg plasma levels were not
different whether polyacrylonitrile hemodialysis was performed
with NSBD or UPBD.
Both TNF-a and IL-6 plasma levels were elevated by the end of
hemodialysis, either with cuprophane or polyacrylonitrile (Table
3). However, TNF-a and IL-6 plasma concentrations were not
higher with NSBD as compared to UPBD, using cuprophane or
polyacrylonitrile. Moreover, MNC were found to be primed
during CU (but not PAN) dialysis to produce TNF-a while
maintained in culture for 24 hours. Again, this effect was not
enhanced by the use of NSBD containing 125 EU/mI of endotoxin
as compared to UPBD. Our results contrast with the findings of
several other groups, who reported higher IL-i [2, 4, 5, 18] or
TNF-a [18] production when hemodialysis was performed with an
endotoxin-containing dialysate. However, it must been empha-
sized that the experimental conditions of these studies were quite
different from the conditions in this study (reviewed in Table 7),
which can explain the contrasting results. (1) All these groups
used E. coli endotoxin, either purified [2, 5, 18] or an E. co/i
microfiltrate [4] added to the dialysate. Now, the source of the
endotoxin might influence the monokines production associated
with hemodialysis, since different endotoxins affect the inflamma-
tory reaction to different levels [14]. Recently, endotoxins present
in the bicarbonate dialysate were shown to be about 100 times less
potent as compared to endotoxins from E. co/i in their ability to
stimulate monokines synthesis [21]. (2) Most important, all these
groups used huge concentrations of endotoxin (0.8 to 10.8 tg/ml,
that is, about 4,000 to 54,000 EU/ml), which are at least one
hundred times higher than the endotoxin contamination of dialy-
sate fluids used for clinical dialysis [22]. In the present study, the
endotoxin concentrations obtained in the NSBD were far less,
while remaining higher than those found in most clinical condi-
tions, where 88% of the values are below 5 EU/mI [22], and the
worst being around 50 EU/ml [23]. Taken together, our results
and those in the literature are consistent with the concept that it
is not the presence, but rather the concentration of endotoxin in
the dialysate that is the relevant issue. According to our experi-
ments, the levels of endotoxin generally present in the dialysate
for clinical use do not stimulate the synthesis of monokines. (3)
Moreover, only one group [2] used blood in the blood circuit and
none used bicarbonate dialysate. It has been shown that the
nature of the fluids used in the blood and dialysate circuits affect
the transport of the cytokines-inducing products through the
dialysis membranes [4, 18]. For instance, the transmembrane
passage of cytokine-inducing substances has been studied by most
other groups using in vitro models in which saline or saline
supplemented with cell culture medium, 5% albumin or 10%
plasma rather than whole blood was used in the blood compart-
ment (Table 7). However, the recent characterization of the
bactericidal/permeability increasing factor (BPI) question the
relevance of these models. Indeed, the BPI, which is released
during hemodialysis [24], may bind to endotoxin and neutralize its
effect. Hence, in vitro models that do not use blood may overes-
timate the effect of cytokine-inducing bacterial substances that
cross the HD membrane. For all these reasons, we believe that
our experimental conditions, using whole blood and bicarbonate
dialysate with endotoxins levels found in clinical conditions, are a
much closer representation of the conditions present during
clinical hemodialysis. Applied to the in vivo situation, our results
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are consistent with the finding in recent prospective studies that
bacterial contamination of the dialysate is not associated with a
significantly increased risk of pyrogenic reactions [231. Both
cuprophane and complement activation products have been
shown to prime monocytes to respond to endotoxin by cytokines
production [25—27]. Hence, if significant amounts of endotoxin
had been able to cross the dialysis membranes, we would have
expected that NSBD hemodialysis would have been associated
with significantly higher production of TNF-a as compared to
dialysis with UPBD. At last, it must also be noticed that TNF-a
production was higher with cuprophane than polyacrylonitrile,
which is consistent with previous results in other in vitro [28] and
in vivo [29] experiments.
Leukocytes express at their surface several glycoproteins such
as the integrins, selectins and CD45, which are involved in
numerous immune functions and in the regulation of the cell
activation state, The expression of these molecules can be up- or
down-regulated under the influence of various stimuli.
Integrins are a family of cxlf3 heterodimeric glycoproteins.
Mac-i and LFA-1 belong to the f32 subfamily of integrins,
characterized by the nature of its (3chain, which is called CD18.
The a chain is variable and characteristic of each individual
integrin: CD11b in the case of Mac-I and CD11a in that of LFA-1.
Mac-i and LFA-i are also known as leukocyte integrins since
their expression is restricted to white blood cells [30].
Mac-i (also called Mo I, CR3, C3bi receptor, and CD11b/
CD 18) is expressed mainly at the surface of PMN, MNC, and
natural killer cells. Upon stimulation, Mac-i is recruited from a
preformed intracellular pool [31, 32] and is quickly up-regulated
at the cell surface. Known stimuli include C5a, fMLP, leukotriene
B4 [33], and endotoxin [16]. Ligands comprise the intercellular
cell adhesion molecule 1 (ICAM-1) [34], C3bi, various microor-
ganisms and endotoxin [reviewed in 33]. Mac-i is involved in
numerous immune functions such as cell adherence and aggrega-
tion, chemotaxis, phagocytosis, and cell lysis (antibody-dependent
cytotoxicity). LFA-1 (leukocyte function antigen i, also known as
gp 180/95 and CDlia/CD18) is strongly expressed on leukocytes.
Counter receptors are ICAM-1 and ICAM-2. LFA-I is involved in
T cell proliferation and activation, and in leukocyte adherence
and aggregation [reviewed in 33].
CD45 (leukocyte common antigen or T200) is a transmcmbrane
glycoprotein expressed on all nucleated hematopoietic cells. The
extracellular domain is probably involved in specific interaction
with proteins. The intracellular domain has a tyrosine phos-
phatase activity and appears to be involved in signal transduction
after stimulation through a number of surface receptors. CD45
might function to dephosphorylate a tyrosine residue on protein
tyrosine kinases involved in receptor-mediated second messenger
formation [reviewed in 35]. In the case of MNC, CD45 seems to
be implicated namely in tumor necrosis factor-a and interleu-
kin-1f3 release [36] and might play anti-adhesive functions [371.
Several in vivo studies have shown that hemodialysis, either with
cuprophane or polyacrylonitrile, is associated with increased
expression on peripheral PMN and MNC of Mac-i [13, 38—42]
and CD45 [13, 43]. However, the time course of leukocytes
integrins and CD45 expression is dependent on cell type and on
the nature of the dialysis membrane, suggesting that different
triggering mechanisms might be implicated [13]. The pattern of
Mac-i and CD45 up-regulation during in vivo hemodialysis has
led to the hypothesis that both complement activation and the
transfer across the membrane of bacterial products arising from
the dialysate might be implicated [i3]. However, the results of the
present study invalidate the hypothesis that bacterial contamina-
tion of the dialysate— even those encountered in the worst clinical
conditions—could induce an increased expression of Maci, LFA-i
or CD45 on PMN and MNC (Tables 5 and 6). Of course, this does
not exclude that much higher concentrations of endotoxin, but
less than what should been encountered in the conditions of
clinical dialysis, could influence the expression of integrins and
CD45.
The behavior of Maci and CD45 at the surface of PMN and
MNC during our in vitro hemodialysis experiments on cuprophane
and polyacrylonitrile was very similar to the one reported previ-
ously during in vivo hemodialysis [13, 38—4 1, 43]. The only notable
difference is the fact that during in vitro hemodialysis, the expres-
sion of Maci and CD45 on PMN still increased from 15 to 180
minutes. This difference might be easily explained by the different
profile in the concentration of complement activation products
and might emphasize the major role of these products in the
up-regulation on PMN of both Maci [31, 32] and CD45 [i7].
Indeed, during in vivo dialysis, complement activation was maxi-
mal around 15 minutes [13]; on the contrary, during close circuit
in vitro hemodialysis, the concentration of complement activation
products are even higher after 180 minutes (Table 2), presumably
because their biological clearance is limited. At the surface of
MNC, Maci and CD45 behaved similarly during in vitro as
compared to in vivo cuprophane hemodialysis, being already
increased at 15 minutes and peaking at the end of the session. As
in vivo, during polyacrylonitrile in vitro dialysis, the levels of Maci
and CD45 on both PMN and MNC remained unchanged after 15
minutes but were much increased after three hours. These
similarities between in vivo hemodialysis (where many leukocytes
leave the systemic circulation to be trapped in the lung circulation
[44]) and in vitro hemodialysis (where the leukocytes are confined
to the closed blood circuit) also suggest that the expression of
Maci and CD45 on the circulating leukocytes in vivo is represen-
tative of the expression of these molecules by the whole leukocyte
population.
In contrast with in vivo hemodialysis [13, 40], there was a mild
but significant increase in the expression of LFA-1 on PMN and
MNC, both with cuprophane and polyacrylonitrile, and whatever
the dialysate. This discrepancy between in vivo and in vitro
hemodialysis might suggest that the cells expressing more LFA-i
leave the systemic blood circulation during in vivo dialysis.
In summary, our in vitro hemodialysis experiments show that
the bacterial contamination of bicarbonate dialysate, at least at
the levels observed in clinical hemodialysis, neither enhances the
level of complement activation nor the secretion of the monokines
TNF-a and IL-6 associated with cuprophane and polyacrylonitrile
hemodialysis. Our results also suggest that cuprophane and
polyacrylonitrile membranes themselves, and especially their
complement activation properties, but not bacterial contamina-
tion of the dialysate, play the major role in the overexpression of
Mac-i, and CD45 observed at the surface of PMN and MNC. In
the case of cuprophane hemodialysis, we speculate that the
complement activation products present in the plasma and on the
membrane are a most important trigger [45]. In the case of
polyacrylonitrile dialysis, this role can be allocated to the comple-
ment activation products which are massively adsorbed on the
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membrane [201. At least with cuprophane, the complement acti-
vation products that are membrane bound are known to remain
functionally active and involved in the adherence of leukocytes to
the membrane [451. Whether bicarbonate dialysate for clinical use
should be ultrapure and pyrogen-free will probably constitute an
important debate of the next years in the field of dialysis. To solve
such a complex issue all aspects of the inflammatory reaction that
can be triggered by bacterial products will need to be investigated.
In this setting, although negative, our data on complement,
monokines, 2-integrins, and CD45 constitute a contribution to
be added to an intricate file.
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